Isatuximab With or Without Lenalidomide in Patients With High Risk Smoldering Multiple Myeloma (ISAMAR)

Conditions

• Smoldering Plasma Cell Myeloma

Interventions

• BIOLOGICAL: Isatuximab
• OTHER: Laboratory Biomarker Analysis

Sponsor

M.D. Anderson Cancer Center

Collaborators

• [object Object]